109 related articles for article (PubMed ID: 23558990)
1. IGF2 expression in blood is not associated with its imprinting status in healthy pregnant Chinese women.
Ru-Fei G; Xue-Qing L; Ying-Xiong W; Xue-Mei C; Yu-Bin D; Jun-Lin H
Biol Res; 2012; 45(4):351-6. PubMed ID: 23558990
[TBL] [Abstract][Full Text] [Related]
2. Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer.
Zuo QS; Yan R; Feng DX; Zhao R; Chen C; Jiang YM; Cruz-Correa M; Casson AG; Kang XD; Han F; Chen T
Mol Carcinog; 2011 May; 50(5):390-6. PubMed ID: 21268128
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of IGF2 imprinting status and the levels of folate biomarkers in second trimester pregnant Chinese women.
Gao RF; He JL; Liu XQ; Ding YB; Chen XM; Chen Q; Tan Y; Wang YX
J Reprod Med; 2011; 56(5-6):254-60. PubMed ID: 21682122
[TBL] [Abstract][Full Text] [Related]
4. Loss of imprinting of IGF2 in Ewing's sarcoma.
Zhan S; Shapiro DN; Helman LJ
Oncogene; 1995 Dec; 11(12):2503-7. PubMed ID: 8545106
[TBL] [Abstract][Full Text] [Related]
5. [Study on the expression and genomic imprinting status of insulin-like growth factor 2 gene in hepatocellular carcinoma].
Li H; Zhang N
Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):347-9. PubMed ID: 15225429
[TBL] [Abstract][Full Text] [Related]
6. IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma.
Murata A; Baba Y; Watanabe M; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Iwagami S; Yoshida N; Oki E; Morita M; Nakao M; Baba H
Ann Surg Oncol; 2014 Apr; 21(4):1166-74. PubMed ID: 24318096
[TBL] [Abstract][Full Text] [Related]
7. Association of 11q loss, trisomy 12, and possible 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor.
Watanabe N; Nakadate H; Haruta M; Sugawara W; Sasaki F; Tsunematsu Y; Kikuta A; Fukuzawa M; Okita H; Hata J; Soejima H; Kaneko Y
Genes Chromosomes Cancer; 2006 Jun; 45(6):592-601. PubMed ID: 16518847
[TBL] [Abstract][Full Text] [Related]
8. LOI of IGF2 is associated with esophageal cancer and linked to methylation status of IGF2 DMR.
Xu W; Fan H; He X; Zhang J; Xie W
J Exp Clin Cancer Res; 2006 Dec; 25(4):543-7. PubMed ID: 17310846
[TBL] [Abstract][Full Text] [Related]
9. Loss of genomic imprinting of insulin-like growth factor 2 is strongly associated with cellular proliferation in normal hematopoietic cells.
Hofmann WK; Takeuchi S; Frantzen MA; Hoelzer D; Koeffler HP
Exp Hematol; 2002 Apr; 30(4):318-23. PubMed ID: 11937266
[TBL] [Abstract][Full Text] [Related]
10. Loss of imprinting of insulin-like growth factor 2 is associated with increased risk of primary lung cancer in the central China region.
Zhang M; Wu CH; Zhu XL; Wang YJ
Asian Pac J Cancer Prev; 2014; 15(18):7799-803. PubMed ID: 25292066
[TBL] [Abstract][Full Text] [Related]
11. Loss of imprinting of the insulin-like growth factor II gene in renal cell carcinoma.
Nonomura N; Nishimura K; Miki T; Kanno N; Kojima Y; Yokoyama M; Okuyama A
Cancer Res; 1997 Jul; 57(13):2575-7. PubMed ID: 9205056
[TBL] [Abstract][Full Text] [Related]
12. [The expression and imprinting status of insulin-like growth factor 2 gene in colorectal cancer].
Zhang FR; He XB; Yang YH; Xie W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):31-4. PubMed ID: 12579496
[TBL] [Abstract][Full Text] [Related]
13. [Loss of imprinting of IGF2 in cord blood of newborns of Chinese Han population].
Dai YM; Hu YL; Wang ZQ; Li J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):10-4. PubMed ID: 17285535
[TBL] [Abstract][Full Text] [Related]
14. [Effect of recombinant adenovirus Ad-DT-A in targeted therapy for malignant cancer cell lines with loss of IGF2 imprinting].
Pan YQ; He BS; Zhu C; Qu LL; Xu XF; Wang SK
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):816-21. PubMed ID: 22335945
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological characteristics of colorectal cancers with loss of imprinting of insulin-like growth factor 2.
Sasaki J; Konishi F; Kawamura YJ; Kai T; Takata O; Tsukamoto T
Int J Cancer; 2006 Jul; 119(1):80-3. PubMed ID: 16432831
[TBL] [Abstract][Full Text] [Related]
16. Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
Vu TH; Chuyen NV; Li T; Hoffman AR
Cancer Res; 2003 Apr; 63(8):1900-5. PubMed ID: 12702581
[TBL] [Abstract][Full Text] [Related]
17. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor.
Ravenel JD; Broman KW; Perlman EJ; Niemitz EL; Jayawardena TM; Bell DW; Haber DA; Uejima H; Feinberg AP
J Natl Cancer Inst; 2001 Nov; 93(22):1698-703. PubMed ID: 11717330
[TBL] [Abstract][Full Text] [Related]
18. [The aberrant imprinting of insulin-like growth factor II and H19 in human hepatocellular carcinoma].
Wu J; Qin Y; Li B; He WZ; Sun ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):49-52. PubMed ID: 17294726
[TBL] [Abstract][Full Text] [Related]
19. Loss of imprinting of IGF2 in fibroadenomas and phyllodes tumors of the breast.
Mishima C; Kagara N; Tanei T; Naoi Y; Shimoda M; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Oncol Rep; 2016 Mar; 35(3):1511-8. PubMed ID: 26676988
[TBL] [Abstract][Full Text] [Related]
20. Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissues.
Zhao R; DeCoteau JF; Geyer CR; Gao M; Cui H; Casson AG
Carcinogenesis; 2009 Dec; 30(12):2117-22. PubMed ID: 19843644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
